Knott David M Jr
Top Portfolio Positions
71 positions ·
$124,670,337 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| APO |
Apollo Global Management, Inc.
Financial Services
|
225,000 | $25,069,500 | 20.11% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
422,000 | $9,857,920 | 7.91% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
90,000 | $6,683,400 | 5.36% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
63,000 | $6,640,200 | 5.33% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
1,060,000 | $6,148,000 | 4.93% | |
| JPM |
Jpmorgan Chase & Co
Financial Services
|
19,477 | $5,729,354 | 4.60% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
1,600,000 | $5,616,000 | 4.50% | |
| ALKS |
Alkermes plc.
Healthcare
|
120,000 | $4,243,200 | 3.40% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
140,633 | $4,178,206 | 3.35% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
104,000 | $4,002,960 | 3.21% |
Portfolio Trend
Holdings in XERS
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,148,000 | 1,060,000 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,614,500 | 970,000 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $8,262,100 | 1,015,000 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,950,200 | 1,060,000 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $6,093,900 | 1,110,000 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,390,000 | 1,000,000 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,850,000 | 1,000,000 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,845,000 | 820,000 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,326,000 | 600,000 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $911,588 | 387,910 | Shares | Defined | 2024-02-13 | |
| No 13F history on record for this holder in this stock. | ||||||